nach oben

Current Atherosclerosis Reports

Erschienen in:

01.07.2016 | Lipid and Metabolic Effects of Gastrointestinal Surgery (R. Cohen, Section Editor)

How to Choose the Best Metabolic Procedure?

verfasst von: Lidia Castagneto Gissey, James Rossario Casella Mariolo, Geltrude Mingrone

Erschienen in: Current Atherosclerosis Reports | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Bariatric/metabolic surgery has proven to be effective in inducing and maintaining diabetes remission—although with a percentage of patients undergoing hyperglycemia relapse—weight loss, and improvement of the cardiovascular risk. It is, however, associated with mortality, although low, and early and late complications. In particular, metabolic complications are related to vitamin deficiency due to the erratic absorption of the supplemented vitamins and to the unpredictable compliance of patients to vitamin and trace element supplementation. In addition, often, the general practitioners and even the specialists are unaware of the clinical effects of metabolic dysfunction following malabsorptive surgery. The choice of the surgical procedure should be the balance between benefits and risks. Our review addresses this important question trying to give some suggestions.

World Health Organization (WHO), World Health Statistics, Fact Sheet N.311: http://www.who.int/mediacentre/factsheets/fs311/en/

Yu J, Zhou X, Li L, Li S, Tan J, Li Y, et al. The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence. Obes Surg. 2015;25(1):143–58. doi:10.1007/s11695-014-1460-2.CrossRefPubMed

Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275–87. doi:10.1001/jamasurg.2013.3654.CrossRefPubMedPubMedCentral

4.•

Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934. doi:10.1136/bmj.f5934. This is a review of randomized controlled trials with a follow-up ≥6 months comparing bariatric-metabolic surgery with medical treatment for type 2 diabetes and meta-analysis of results from 11 studies including 796 individuals with BMI ranging from 30 to 50 kg/m2. CrossRefPubMedPubMedCentral

5.••

Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–73. doi:10.1016/S0140-6736(15)00075-6. This is, at the moment, the only long-term randomized controlled study (follow-up at 5 years) reporting the effects of bariatric-metabolic surgery on type 2 diabetes remission in comparison with medical treatment. CrossRefPubMed

6.•

Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85. doi:10.1056/NEJMoa1200111. This randomized controlled study reports the effects of bariatric-metabolic surgery, including gastric bypass and bilio-pancreatic diversion, versus medical therapy on type 2 diabetes remission at 2 years. CrossRefPubMed

Lee GK, Cha YM. Cardiovascular benefits of bariatric surgery. Trends Cardiovasc Med. 2015. doi:10.1016/j.tcm.2015.07.006 [Epub ahead of print].PubMed

Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65. doi:10.1001/jama.2011.1914.CrossRefPubMed

NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956–61.CrossRef

10.

Brolin RE. Update: NIH consensus conference. Gastrointestinal surgery for severe obesity. Nutrition. 1996;12:403–4.CrossRefPubMed

11.

Dixon JB, Zimmet P, Alberti KG, Rubino F, International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28(6):628–42. doi:10.1111/j.1464-5491.2011.03306.x.CrossRefPubMedPubMedCentral

12.

Obesity: identification, assessment and management NICE clinical guidelines; Published date: November 2014: https://www.nice.org.uk/guidance/cg189

13.

Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93(7):2479–85. doi:10.1210/jc.2007-2851.CrossRefPubMedPubMedCentral

14.

Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015;3(3):207–15. doi:10.1016/S2213-8587(14)70134-2.CrossRefPubMed

15.

Dalmas E, Venteclef N, Caer C, Poitou C, Cremer I, Aron-Wisnewsky J, et al. T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes. 2014;63(6):1966–77. doi:10.2337/db13-1511.CrossRefPubMed

16.

Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145(5):2273–82.CrossRefPubMed

17.

Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489(7415):242–9. doi:10.1038/nature11552.CrossRefPubMed

18.

Yousseif A, Emmanuel J, Karra E, Millet Q, Elkalaawy M, Jenkinson AD, et al. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes Surg. 2014;24(2):241–52. doi:10.1007/s11695-013-1066-0.CrossRefPubMed

19.

Food and Drug administration; Lap-Band Adjustable Gastric Banding System: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm248133.htm

20.

Angrisani L, Cutolo PP, Formisano G, Nosso G, Santonicola A, Vitolo G. Long-term outcomes of laparoscopic adjustable silicone gastric banding (LAGB) in moderately obese patients with and without co-morbidities. Obes Surg. 2013;23(7):897–902. doi:10.1007/s11695-013-0877-3.CrossRefPubMed

21.

Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.CrossRefPubMed

22.

Michalik M, Lech P, Bobowicz M, Orlowski M, Lehmann A. A 5-year experience with laparoscopic adjustable gastric banding—focus on outcomes, complications, and their management. Obes Surg. 2011;21(11):1682–6. doi:10.1007/s11695-011-0453-7.CrossRefPubMed

23.

Lanthaler M, Aigner F, Kinzl J, Sieb M, Cakar-Beck F, Nehoda H. Long-term results and complications following adjustable gastric banding. Obes Surg. 2010;20(8):1078–85. doi:10.1007/s11695-010-0190-3.CrossRefPubMed

24.

Cottam DR, Atkinson J, Anderson A, Grace B, Fisher B. A case-controlled matched pair cohort study of laparoscopic Roux-en-Y gastric bypass and Lap-Band patients in a single US center with three-year follow-up. Obes Surg. 2006;16(5):534–40.CrossRefPubMed

25.

Kim TH, Daud A, Ude AO, DiGiorgi M, Olivero-Rivera L, Schrope B, et al. Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc. 2006;20(2):202–9. Epub 2005 Dec 6.CrossRefPubMed

26.

Hutter MM, Schirmer BD, Jones DB, Ko CY, Cohen ME, Merkow RP, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254(3):410–20. doi:10.1097/SLA.0b013e31822c9dac. discussion 420-2.CrossRefPubMedPubMedCentral

27.

Favretti F, Segato G, Ashton D, Busetto L, De Luca M, Mazza M, et al. Laparoscopic adjustable gastric banding in 1,791 consecutive obese patients: 12-year results. Obes Surg. 2007;17(2):168–75.CrossRefPubMed

28.

29.

Naef M, Mouton WG, Naef U, Kummer O, Muggli B. Wagner HE Graft survival and complications after laparoscopic gastric banding for morbid obesity—lessons learned from a 12-year experience. Obes Surg. 2010;20(9):1206–14. doi:10.1007/s11695-010-0205-0.CrossRefPubMed

30.

Bowne WB, Julliard K, Castro AE, Shah P, Morgenthal CB, Ferzli GS. Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients: a prospective, comparative analysis. Arch Surg. 2006;141(7):683–9.CrossRefPubMed

31.

O’Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257(1):87–94. doi:10.1097/SLA.0b013e31827b6c02.CrossRefPubMed

32.

Chakravarty PD, McLaughlin E, Whittaker D, Byrne E, Cowan E, Xu K, et al. Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures; a systematic review of the randomised controlled trials. Surgeon. 2012;10(3):172–82. doi:10.1016/j.surge.2012.02.001.CrossRefPubMed

33.

Brethauer SA, Aminian A, Romero-Talamás H, Batayyah E, Mackey J, Kennedy L, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–36. doi:10.1097/SLA.0b013e3182a5034b. discussion 636-7.PubMedPubMedCentral

34.

Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641. doi:10.1002/14651858.CD003641.pub4.PubMed

35.

Wang S, Li P, Sun XF, Ye NY, Xu ZK, Wang D. Comparison between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding for morbid obesity: a meta-analysis. Obes Surg. 2013;23(7):980–6. doi:10.1007/s11695-013-0893-3.CrossRefPubMedPubMedCentral

36.

Diamantis T, Apostolou KG, Alexandrou A, Griniatsos J, Felekouras E, Tsigris C. Review of long-term weight loss results after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(1):177–83. doi:10.1016/j.soard.2013.11.007.CrossRefPubMed

37.

Marceau P, Biron S, Marceau S, Hould FS, Lebel S, Lescelleur O, et al. Biliopancreatic diversion-duodenal switch: independent contributions of sleeve resection and duodenal exclusion. Obes Surg. 2014;24(11):1843–9. doi:10.1007/s11695-014-1284-0.CrossRefPubMed

38.

Biertho L, Simon-Hould F, Marceau S, Lebel S, Lescelleur O, Biron S. Current outcomes of laparoscopic duodenal switch. Ann Surg Innov Res. 2016;10:1. doi:10.1186/s13022-016-0024-7.CrossRefPubMedPubMedCentral

39.

Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg. 2005;15(3):408–16.CrossRefPubMed

40.

O’Brien PE, McPhail T, Chaston TB, Dixon JB. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006;16(8):1032–40.CrossRefPubMed

41.

Biertho L, Lebel S, Marceau S, Hould FS, Lescelleur O, Marceau P, et al. Laparoscopic sleeve gastrectomy: with or without duodenal switch? A consecutive series of 800 cases. Dig Surg. 2014;31(1):48–54. doi:10.1159/000354313.CrossRefPubMed

42.

Puzziferri N, Roshek 3rd TB, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):934–42. doi:10.1001/jama.2014.10706.CrossRefPubMedPubMedCentral

43.

Li JF, Lai DD, Lin ZH, Jiang TY, Zhang AM, Dai JF. Comparison of the long-term results of Roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of randomized and nonrandomized trials. Surg Laparosc Endosc Percutan Tech. 2014;24(1):1–11. doi:10.1097/SLE.0000000000000041.CrossRefPubMed

44.

Cho JM, Kim HJ, Lo Menzo E, Park S, Szomstein S, Rosenthal RJ. Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis. Surg Obes Relat Dis. 2015;11(6):1273–80. doi:10.1016/j.soard.2015.03.001.CrossRefPubMed

45.

46.

Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248-256.e5. doi:10.1016/j.amjmed.2008.09.041.CrossRefPubMed

47.

Bolckmans R, Himpens J. Long-term (>10 yrs) outcome of the laparoscopic biliopancreatic diversion with duodenal switch. Ann Surg. 2016;13 [Epub ahead of print].

48.

Marceau P, Biron S, Hould FS, Lebel S, Marceau S, Lescelleur O, et al. Duodenal switch: long-term results. Obes Surg. 2007;17(11):1421–30.CrossRefPubMed

49.

Nelson DW, Blair KS, Martin MJ. Analysis of obesity-related outcomes and bariatric failure rates with the duodenal switch vs gastric bypass for morbid obesity. Arch Surg. 2012;147(9):847–54. doi:10.1001/archsurg.2012.1654.CrossRefPubMed

50.

Li J, Lai D, Wu D. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg. 2016;26(2):429–42. doi:10.1007/s11695-015-1996-9.CrossRefPubMed

51.

Favretti F, Ashton D, Busetto L, Segato G, De Luca M. The gastric band: first-choice procedure for obesity surgery. World J Surg. 2009;33(10):2039–48. doi:10.1007/s00268-009-0091-6.CrossRefPubMed

52.

Mans E, Serra-Prat M, Palomera E, Suñol X, Clavé P. Sleeve gastrectomy effects on hunger, satiation, and gastrointestinal hormone and motility responses after a liquid meal test. Am J Clin Nutr. 2015;102(3):540–7. doi:10.3945/ajcn.114.104307.CrossRefPubMed

53.

Paulus GF, de Vaan LE, Verdam FJ, Bouvy ND, Ambergen TA, van Heurn LW. Bariatric surgery in morbidly obese adolescents: a systematic review and meta-analysis. Obes Surg. 2015;25(5):860–78. doi:10.1007/s11695-015-1581-2.CrossRefPubMedPubMedCentral

54.

Khan S, Rock K, Baskara A, Qu W, Nazzal M, Ortiz J. Trends in bariatric surgery from 2008 to 2012. Am J Surg. 2015. doi:10.1016/j.amjsurg.2015.10.012 [Epub ahead of print].

55.

DeMaria EJ, Pate V, Warthen M, Winegar DA. Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2010;6(4):347–55. doi:10.1016/j.soard.2009.11.015.CrossRefPubMed

56.

Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32. doi:10.1007/s11695-015-1657-z.CrossRefPubMed

57.

Gluck B, Movitz B, Jansma S, Gluck J, Laskowski K. Laparoscopic sleeve gastrectomy is a safe and effective bariatric procedure for the lower BMI (35.0–43.0 kg/m2) population brian. Obes Surg. 2011;21(8):1168–71. doi:10.1007/s11695-010-0332-7.CrossRefPubMed

58.

Oor JE, Roks DJ, Ünlü Ç, Hazebroek EJ. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Surg. 2016;211(1):250–67. doi:10.1016/j.amjsurg.2015.05.031.CrossRefPubMed

59.

Miller K, Pump A, Hell E. Vertical banded gastroplasty versus adjustable gastric banding: prospective long-term follow-up study. Surg Obes Relat Dis. 2007;3(1):84–90. Epub 2006 Nov 20.CrossRefPubMed

60.

Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL, et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005;90(1):359–65.CrossRefPubMed

61.

Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66(9):618–20.CrossRefPubMed

62.

Rosenthal RJ, International sleeve gastrectomy expert panel, Diaz AA, Arvidsson D, Baker RS, Basso N, et al. International sleeve gastrectomy expert panel consensus statement: best practice guidelines based on experience of 12,000 cases. Surg Obes Relat Dis. 2012;8(1):8–19. doi:10.1016/j.soard.2011.10.019.CrossRefPubMed

Titel: How to Choose the Best Metabolic Procedure?
verfasst von: Lidia Castagneto Gissey
James Rossario Casella Mariolo
Geltrude Mingrone
Publikationsdatum: 01.07.2016
Verlag: Springer US
Erschienen in: Current Atherosclerosis Reports / Ausgabe 7/2016
Print ISSN: 1523-3804
Elektronische ISSN: 1534-6242
DOI: https://doi.org/10.1007/s11883-016-0590-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2016

Monoclonal Antibodies for Lipid Management

Endovascular Interventions in Acute Ischemic Stroke: Recent Evidence, Current Challenges, and Future Prospects

Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article

The Contribution of Diabetes Education in the Treatment of People with Type 2 Diabetes and Risk of Cardiovascular Disease

Role of cis-Monounsaturated Fatty Acids in the Prevention of Coronary Heart Disease